Genomic Assays in Early Breast Cancer - a podcast by Research To Practice

Dr Kevin Kalinsky from Emory University in Atlanta discusses the role of genomic assays in treatment decision-making for patients with hormone receptor-positive, HER2-negative, early-stage breast cancer.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEarlyBCGenomicAssays21).

Further episodes of Oncology Today with Dr Neil Love

Further podcasts by Research To Practice

Website of Research To Practice